Atomoxetine (brand name Strattera) is a non-stimulant medication approved for the treatment of attention deficit hyperactivity disorder (ADHD) in children, adolescents, and adults.
It is used to manage core ADHD symptoms such as inattention, hyperactivity, and impulsivity when stimulant medications are not suitable or have been ineffective.
Atomoxetine works by selectively inhibiting the presynaptic norepinephrine transporter in the central nervous system, increasing extracellular norepinephrine levels and improving neuronal signaling associated with attention and impulse control.